Commissioning Policy Individual Funding Request
|
|
- Sharon Marsh
- 6 years ago
- Views:
Transcription
1 Commissioning Policy Individual Funding Request Continuous Glucose Monitors Prior Approval Policy Date Adopted: 13 October 2017 Version:
2 Document Control Title of document Continuous Glucose Monitors Policy Authors job title(s) IFR Manager Document status v Supersedes New Policy Clinical approval Date sent for clinical approval Discussion and Approval by 14 June 2017 Clinical Policy Review Group (CPRG) Discussion and Approval by CCG 01 August 2017 Board Date of Adoption 13 October 2017 Publication/issue date 08 September 2017 Review date 13 October 2020 Application Form Version Control v Equality and Impact Assessment TBC
3 TREATMENT UNDER THIS POLICY REQUIRES PRIOR APPROVAL FROM THE CCG INDIVIDUAL FUNDING TEAM THIS POLICY RELATES TO ALL PATIENTS over 18 years CONTINUOUS GLUCOSE MONITORS Policy Statement and Date of Adoption: 13 October 2017 Continuous Glucose Monitors (CGM) or Continuous Glucose Monitoring Sensors (CGMS) are not routinely funded by the CCG and are subject to this restricted policy. General Principles Funding approval will only be given in line with these general principles. Where patients are unable to meet these principles in addition to the specific treatment criteria set out in this policy, funding approval will not be given. 1. Funding approval must be secured by primary care prior to referring patients seeking treatment. Referring patients to secondary care without funding approval having been secured not only incurs significant costs in out-patient appointments for patients that may not qualify for treatment, but inappropriately raises the patient s expectation of treatment. 2. In line with the published document Guidance - Who Applies for Funding?, where referrals to secondary care are accepted without funding approval having been secured, responsibility for securing funding approval will fall to secondary care. 3. On limited occasions, the CCG may approve funding for an assessment only in order to confirm or obtain evidence demonstrating whether a patient meets the criteria for funding. In such cases, patients should be made aware that the assessment does not mean that they will be provided with the treatment as this will only be provided where it can be demonstrated that the patient meets the criteria to access treatment in this policy. 4. Where funding approval is given by the Individual Funding Panel, it will be available for a specified period of time, normally one year. 5. Funding approval will only be given where there is evidence that the treatment requested is effective and the patient has the potential to benefit from the proposed treatment. Where it is demonstrated that patients have previously been provided with the treatment with limited or diminishing benefit, funding approval is unlikely to be agreed. 6. Patients with an elevated BMI of 30 or more are likely to receive fewer benefits from surgery and should be encouraged to lose weight further prior to seeking surgery. In addition, the risks of surgery are significantly increased. (Thelwall, 2015) 7. Patients who are smokers should be referred to smoking cessation services in order to reduce the risk of surgery and improve healing. (Loof S., 2014)
4 Background Although self-monitoring of blood glucose plays an important role in achieving target glycated hemoglobin levels, few patients with Type 1 Diabetes measure glucose levels after meals or overnight (i.e. more than 4-6 times a day). Consequently, postprandial hyperglycaemia and asymptomatic nocturnal hypoglycaemia are commonly seen, even in patients with well-controlled Type 1 Diabetes who measure blood glucose several times daily with a home blood glucose meter. Continuous Glucose Monitoring Sensors (CGMS) are devices that would allow for glucose values to be visible continuously, enabling immediate therapeutic adjustments on the basis of real time glucose results. The sensor is inserted subcutaneously and measures interstitial glucose. The real-time monitor shows trends in glucose levels on an LCD display and indicates the rate of glucose change using arrows. They have predictive alarms for low or high glucose level and warn of impending hypoglycaemia or hyperglycaemia (by sounding alarm). Two types of CGMS are available under this Policy: Real time or therapeutic CGMS provide continuous interstitial glucose concentration visible to patient, allowing for strategies for adjusting therapy according to the sensor data. There is an expectation that CGMS will be worn continuously at least 70% of the time. Diagnostic CGMS measure interstitial glucose concentrations during a certain time span, usually 5-10 days; there is no contemporaneous display of sensor readings and the information is downloaded and analysed by a healthcare professional at a later time. Benefits of using CGMS Using real time CGM and either a CSII (insulin pump) or multiple daily insulin injections achieves a significant reduction in HbA1c compared with the HbA1c levels of control patients who used only blood glucose self-monitoring using meters. Using CGMS therapy would save patients frequent testing (since this neither completely prevents all episodes of severe hypoglycaemia nor episodes of hyperglycaemia) and predictive sensor alerts would forewarn them (day and night) when glucose levels are dropping hence allowing them to take preventative actions and significantly decrease frequency of moderate and severe hypoglycaemia, with their physical and social sequelae and improved quality of life. Severe hypoglycaemia, hypoglycaemia unawareness and brittle diabetes lead to increased demand on primary, ambulance and secondary care services.
5 Policy - Criteria to Access Treatment is subject to Prior Approval by the IFR Team The Commissioner will commission the use of a Continuous Glucose Monitor only when the following criteria have been met: 1. The patient must have Type 1 Diabetes. 2. The patient must be using, or will begin using, insulin pump therapy with an Animas Vibe or a Medtronic Veo or a 640g insulin pump. 3. The patient must have: a. documented evidence of at least 2 episodes of hypoglycaemia requiring 3 rd party assistance (i.e. resulting, for example, in the loss of driving licence) OR b. recurrent episodes of hypoglycaemia, hypoglycaemia unawareness or night-time hypoglycaemia not amenable to usual therapeutic interventions* 4. The patient/family/carer must be highly motivated to use a CGM more than 70% of the time. 5. The patient must have documented agreement from an Insulin Pump Multi-Disciplinary Team (MDT) that criteria for use are met. The Commissioner will commission the use of a diagnostic CGMS for the duration of 5 days (and a maximum of 3 weeks in exceptional circumstances) when the following criteria have been met: 1. The patient must have Type 1 Diabetes (on CSII or Multiple Daily Insulin Injections) one of the following indicators: 2. Episodes of hyper/hypoglycaemia after all other issues have been addressed, for example - injection sites/technique, appropriate insulin regime, diabetes education update OR 3. Severe hypoglycaemia and/or hypoglycaemia unawareness OR 4. Nocturnal hypoglycaemia is suspected and difficult to confirm using capillary blood glucose readings OR 5. To demonstrate to the patient that current treatment/insulin regime is not achieving optimal control or if the patient has firm belief that they have recurrent hypoglycaemia with no objective supporting information OR 6. During preconception and pregnancy in a select group of patients.
6 *Strategies and Therapeutic Interventions to Prevent Hypoglycaemia. (Seaquist, E. R. et al. Hypoglycaemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, (2013). Patient education Recognition of hypoglycaemia symptoms Effective treatment of hypoglycaemia Discussion of hypoglycaemia at review consultations, including: Frequency Severity Symptoms and awareness Analysis of events (cause, timing, role of alcohol, etc.) Knowledge of pharmacokinetics of medications Formal training programmes Hypoglycaemia identification training (impaired awareness) Dietary measures Knowledge of carbohydrate content of foods Predictable meal plan Flexible manipulation of insulin regimen and/or dosage Carry fast-acting carbohydrate to treat hypoglycaemia Physical exercise Recognition of potential risk factors (type, duration and timing of exercise) Glucose monitoring related to exercise Prophylactic snacks Insulin dose adjustment Glucose monitoring Routine and ad hoc testing, with records kept in a diary, log or memory facility of glucose meter Capillary blood glucose monitoring Diagnostic and/or real time continuous glucose monitoring (with pre-set alarm) Commencement of CSII, if still on Multiple Daily Insulin Injections Patients who are not eligible for treatment under this policy may be considered on an individual basis where their GP or consultant believes exceptional circumstances exist that warrant deviation from the rule of this policy. Individual cases will be reviewed at the CCG s Individual Funding Request Panel upon receipt of a completed application form from the patient s GP, consultant or clinician. Applications cannot be considered from patients personally. If you would like further copies of this policy or need it in another format, such as Braille or another language, please contact the Patient Advice and Liaison Service on or
7 Connected Policies This policy has been developed with the aid of the following references: BIBLIOGRAPHY Loof S., D. B. (2014). Perioperative complications in smokers and the impact of smoking cessation interventions [Dutch]. Tijdschrift voor Geneeskunde, vol./is. 70/4( Thelwall, S. P. (2015). Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,, vol. 21, no. 11, p e1. Approved by (committee): Clinical Policy Review Group Date Adopted: 13/10/2017 Version: Produced by (Title) Commissioning Manager Individual Funding EIA Completion Date: TBC Undertaken by (Title): Review Date: Earliest of either NICE publication or three years from approval. CATEGORY VERSION CATEGORY VERSION CATEGORY VERSION Bristol Prior Approval North Somerset Prior Approval South Gloucestershire Prior Approval
Commissioning Policy Individual Funding Request
Commissioning Policy Funding Request Abdominal Loose Skin Removal Funding Request Policy Date Adopted: 13 October 2017 Version: 1718.2.0 Funding Request Team - A partnership between Bristol, North Somerset
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Funding Request Congenital Ear Deformity Correction Surgery (including Pinnaplasty) Funding Request Policy Date Adopted: 13 October 2017 Version: 1718.2.0 Funding Request Team - A
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Funding Request Testicular Prosthesis Funding Request Policy Date Adopted: 13 October 2017 Funding Request Team - A partnership between Bristol, North Somerset and South Gloucestershire
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Temporomandibular Jaw Motion Rehabilitation Devices Individual Funding Requests Policy Date Adopted: 4 th November 2016 Version: 1617.1 Individual Funding
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Female Sterilisation Prior Approval Policy Date Adopted: 6 th February 2017 Version: 1617.1 Individual Funding Request Team - A partnership between Bristol,
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Ingrown Toenail Treatment in Secondary Care Individual Funding Request Policy Date Adopted: 13 October 2017 Version: 1718.2.01 Individual Funding Request
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Surgical Intervention for Treatment of Hydrocele (also known as Hydroecoele) in Males Policy Prior Approval Policy Date Adopted: 16 th September 2016 Version:
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Extracorporeal Shockwave Therapy (ESWT) Individual Funding Requests Policy Date Adopted: 6 th February 2017 Version: 1617.1 Individual Funding Request Team
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Surgical Correction of Strabismus or Amblyopia in Adults Prior Approval Policy Date Adopted: 19 th April 2017 Version: v1718.1 Individual Funding Request
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Carpal Tunnel Syndrome Surgery Criteria Based Access Policy Date Adopted: 6 th February 2017 Version: 1617.1.02 Individual Funding Request Team Bristol,
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Vasectomy Policy Criteria Based Access Policy Date Adopted: 6 th February 2017 Version: 1617.1 Individual Funding Request Team - A partnership between Bristol,
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Vitreous Floaters Individual Funding Request Policy Date Adopted: 19 April 2017 Version: 1718.1.01 Individual Funding Request Team Bristol, North Somerset
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Management of Low Back Pain and Sciatica in over 16s Policy Criteria Based Access Policy Date Adopted: August 2017 Version: 1718.1 Individual Funding Request
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Penile Conditions - Surgical Opinion and Treatment Policy including Circumcision in all male patients over the age of 18 years Prior Approval Policy Date
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Hip Replacement Surgery including referral for Surgical Assessment of Osteoarthritis Criteria Based Access Policy Date Adopted: 1 st June 2016 Version: 1617.1.01
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Cataract Surgery Criteria Based Access Policy Date Adopted: 19 th April 2017 Version: 1718.1 Individual Funding Request Team - A partnership between Bristol,
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Hernia Repair in Adults Criteria Based Access Policy Date Adopted: 22 December 2017 Version: 1718.3.01 Individual Funding Request Team - A partnership between
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Laparoscopic Cholecystectomy for Gallstones in Adults Criteria Based Access Policy Date Adopted: 22 December 2017 Version: 1718.3.01 Individual Funding Request
More informationCONTINUOUS GLUCOSE MONITORING POLICY INDIVIDUAL FUNDING
CONTINUOUS GLUCOSE MONITORING POLICY INDIVIDUAL FUNDING Version: 1718.v1 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 12 July 2017 Name of Originator/Author:
More informationAnnual MRI Breast Screening Criteria Based Access Policy Date Adopted: 21st August 2015 Version:
Annual MRI Breast Screening Criteria Based Access Policy Date Adopted: 21st August 2015 Version: 1516.2 Document Control Title of document Annual MRI Breast Screening Authors job title(s) IFR Manager Document
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Individual Funding Request Policy Date Adopted: 21 August 2015 Version: 1516.2.01 Individual Funding Request Team Bristol, North Somerset and South Gloucestershire
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Criteria Based Access Policy Date Adopted: 21 August 2015 Version: 1516.1.01 Individual Funding Request Team Bristol, North Somerset and South Gloucestershire
More informationLOW BACK PAIN AND SCIATICA INTERVENTIONS POLICY IN OVER 16S CRITERIA BASED ACCESS
LOW BACK PAIN AND SCIATICA INTERVENTIONS POLICY IN OVER 16S CRITERIA BASED ACCESS Version: Recommendation by: 1718.v2b Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 12 July 2017
More informationCommissioning Policy. Hernia Repair in Adults. Criteria Based Access. Date Adopted: 22 nd December 2017 Version:
Commissioning Policy Hernia Repair in Adults Criteria Based Access Date Adopted: 22 nd December 2017 Version: 1819.2.00 Title of document: Authors job title(s): Document Control Hernia Repair in Adults
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Tonsillectomy - Referral for Assessment Criteria Based Access and Prior Approval Policy Date Adopted: 04 November 2016 Version: 1617.1.01 Individual Funding
More informationCommissioning Policy. Vitreous Floaters. Date Adopted: 19 th April 2017 Version:
Commissioning Policy Date Adopted: 19 th April 2017 Version: 1819.2.00 Title of document: Authors job title(s): Document Control Policy IFR Manager Document version: 1819.2.00 Supersedes: 1718.1.01 Clinical
More informationLIPOSUCTION (COSMETIC) INDIVIDUAL FUNDING REQUEST POLICY
LIPOSUCTION (COSMETIC) INDIVIDUAL FUNDING REQUEST POLICY Version: Recommendation by: 1617.v2a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 13 July 2016 Name of Originator/Author:
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Continuous Positive Airway Pressure (CPAP) Treatment of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) Criteria Based Access Policy Date Adopted: 13
More informationSurgical Intervention for Simple Snoring Individual Funding Requests Policy
Surgical Intervention for Simple Snoring Individual Funding Requests Policy Version: Recommendation by: 1516.v1.1a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 23 September 2015
More informationBREAST IMPLANT SURGERY INDIVIDUAL FUNDING REQUEST POLICY
BREAST IMPLANT SURGERY INDIVIDUAL FUNDING REQUEST POLICY Version: Recommendation by: 1617.V2b Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 13 July 2016 Name of Originator/Author:
More informationBOTULINUM TOXIN (BOTOX) POLICY HYPERHIDROSIS - PRIOR APPROVAL
BOTULINUM TOXIN (BOTOX) POLICY HYPERHIDROSIS - PRIOR APPROVAL Version: Ratified by: 1617.v2c SCCG COG Date Ratified: 11 May 2016 Name of Originator/Author: Name of Responsible Committee/Individual: IFR
More informationABDOMINOPLASTY/APRONECTOMY INDIVIDUAL FUNDING REQUEST POLICY
ABDOMINOPLASTY/APRONECTOMY INDIVIDUAL FUNDING REQUEST POLICY Version: Ratified by: 1516.v1.2 Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 23 September 2015 Name of Originator/Author:
More informationREVERSAL OF STERILISATION/ VASECTOMY INDIVIDUAL FUNDING REQUEST POLICY
REVERSAL OF STERILISATION/ VASECTOMY INDIVIDUAL FUNDING REQUEST POLICY Version: Recommendation by: 1516.v1.1a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 23 September 2015 Name
More informationOPEN & UPRIGHT MRI PRIOR APPROVAL POLICY
OPEN & UPRIGHT MRI PRIOR APPROVAL POLICY Version: Recommendation by: 1819.v1.3 Date Ratified: June 2018 Name of Originator/Author: Approved by Responsible Committee/Individual: Somerset CCG Clinical Commissioning
More informationTRIGGER FINGER CRITERIA BASED ACCESS POLICY
TRIGGER FINGER CRITERIA BASED ACCESS POLICY Version: Discussion and Recommendation by the Somerset CCG Clinical Commissioning Policy Forum 1617.v1b Date: 16 June 2016 Name of Originator/Author: Name of
More informationEXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) INDIVIDUAL FUNDING REQUESTS POLICY
EXTRACORPOREAL SHOCKWAVE THERAPY (ESWT) INDIVIDUAL FUNDING REQUESTS POLICY Version: 1718.v1 Recommendation by: Date Ratified: 01 November 2017 Name of Originator/Author: Approved by Responsible Committee/Individual:
More informationBUNION (AND OTHER PAINFUL TOE CONDITION) SURGICAL TREATMENT POLICY PRIOR APPROVAL
BUNION (AND OTHER PAINFUL TOE CONDITION) SURGICAL TREATMENT POLICY PRIOR APPROVAL Version: 1718.v3 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 12 July 2017
More informationPERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) TREATMENT FOR URINARY INCONTINENCE SECONDARY CARE PRIOR APPROVAL POLICY
PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) TREATMENT FOR URINARY INCONTINENCE SECONDARY CARE PRIOR APPROVAL POLICY Version: Recommendation by: 1617v2a Somerset CCG Clinical Commissioning Policy Forum
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Knee Replacement Surgery (including Partial and Total Knee Replacement with or without Patella Replacement or Resurfacing) Criteria Based Access Policy Date
More informationCARPAL TUNNEL SURGERY CRITERIA BASED ACCESS POLICY
CARPAL TUNNEL SURGERY CRITERIA BASED ACCESS POLICY Version: 1516.2c Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 11 May 2016 Name of Originator/Author: Approved
More informationGROMMET INSERTION RECURRENT ACUTE OTITIS MEDIA (WITHOUT EFFUSION) SECONDARY CARE PRIOR APPROVAL POLICY
Version: 1718.v1 Ratified by: SCCG COG Date Ratified: 05 April 2017 Name of Originator/Author: Name of Responsible Committee/Individual: IFR SCCG CCPF/ IFR Date issued: 18 April 2017 Review date: Target
More informationCommissioning Policy
Commissioning Policy Abbott FreeStyle Libre Flash Glucose Monitoring System Individual Funding Request Date Adopted: 09 September 2018 Version: 1819.1.02 Title of document: Authors job title(s): Document
More informationABDOMINOPLASTY/APRONECTOMY INDIVIDUAL FUNDING REQUEST POLICY
ABDOMINOPLASTY/APRONECTOMY INDIVIDUAL FUNDING REQUEST POLICY Version: Recommendation by: 1819.v1.3 Date Ratified: June 2018 Name of Originator/Author: Approved by Responsible Committee/Individual: Somerset
More informationCATARACT REFERRAL FOR ASSESSMENT OF SURGICAL TREATMENT CRITERIA BASED ACCESS POLICY
CATARACT REFERRAL FOR ASSESSMENT OF SURGICAL TREATMENT CRITERIA BASED ACCESS POLICY Version: Recommendation by: 1516.V1a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: MAY 2015
More informationHip Replacement Surgery Including referral for Surgical Assessment of Osteoarthritis Criteria Based Access Policy
Hip Replacement Surgery Including referral for Surgical Assessment of Osteoarthritis Criteria Based Access Policy Version: 1617.v6 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF)
More informationDEXA SCAN POLICY CRITERIA BASED ACCESS
DEXA SCAN POLICY Version: 1718.v2 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 01 November 2017 Name of Originator/Author: Approved by Responsible Committee/Individual:
More informationGROMMET INSERTION IN ADULTS WITH OTITIS MEDIA WITH EFFUSION (OME) SECONDARY CARE PRIOR APPROVAL POLICY
SECONDARY CARE PRIOR APPROVAL POLICY Version: Recommendation by: 1617.v3a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 13 July 2016 Name of Originator/Author: Approved by Responsible
More informationADENOIDECTOMY SECONDARY CARE PRIOR APPROVAL POLICY 1516.v1b
ADENOIDECTOMY SECONDARY CARE PRIOR APPROVAL POLICY Version: Ratified by: Somerset CCG COG Date Ratified: March 2016 Name of Originator/Author: Name of Responsible Committee/Individual: IFR Manager SCCG
More informationShoulder Impingement Surgery for Subacromial Pain Policy CRITERIA BASED ACCESS
Shoulder Impingement Surgery for Subacromial Pain Policy CRITERIA BASED ACCESS Version: 1718.v2 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 12 July 2017 Name
More informationBENIGN SKIN LESIONS INDIVIDUAL FUNDING REQUEST POLICY
BENIGN SKIN LESIONS INDIVIDUAL FUNDING REQUEST POLICY Version: 1516.v3 Ratified by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 23 March 2017 Name of Originator/Author: Name
More informationTONSILLECTOMY PRIOR APPROVAL POLICY
TONSILLECTOMY PRIOR APPROVAL POLICY Version: Recommendation by: 1516.v3a Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: August 2015 Name of Originator/Author: Approved by Responsible
More informationHYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING
HYPERHIDROSIS TREATMENT POLICY INDIVIDUAL FUNDING Version: 1718.v3 Ratified by: SCCG COG Date Ratified: 01 November 2017 Name of Originator/Author: Name of Responsible Committee/Individual: IFR Manager
More informationCataract Policy. (Referral for Assessment of Surgical Treatment)
Cataract Policy (Referral for Assessment of Surgical Treatment) MAY 2015 Document Control Title of document Cataract Policy Authors name(s) Authors job title(s) IFR Team Directorate(s) IFR Document status
More informationGROMMET INSERTION 18 YEARS AND UNDER PERSISTENCE OF BILATERAL OTITIS MEDIA WITH EFFUSION SECONDARY CARE PRIOR APPROVAL POLICY
SECONDARY CARE PRIOR APPROVAL POLICY Version: 1718.v3 Ratified by: Date Ratified: 05 April 2017 Name of Originator/Author: Name of Responsible Committee/Individual: Somerset CCG Clinical Commissioning
More informationPolicy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (<18 years of age)
Policy for Continuous Glucose Monitoring for Type 1 Diabetic Paediatric Patients (
More informationPolicy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the
More informationKnee Arthoscopy with or without Debridement Policy CRITERIA BASED ACCESS
Knee Arthoscopy with or without Debridement Policy CRITERIA BASED ACCESS Version: 1718.v2 Ratified by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Somerset CCG Clinical Operations Group (COG)
More informationPlacename CCG. Policies for the Commissioning of Healthcare
Placename CCG Policies for the Commissioning of Healthcare Policy for the funding of insulin pumps and continuous glucose monitoring devices for patients with diabetes 1 Introduction 1.1 This document
More informationPlacename CCG. Policies for the Commissioning of Healthcare
Placename CCG Policies for the Commissioning of Healthcare Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus. This document is part
More informationCommissioning Statement
Commissioning Statement Treatment/ device For the treatment of Commissioning position Flash Glucose Monitoring Systems (including Freestyle Libre ) Monitoring glucose levels in adults and children over
More informationCommissioning Statement. Flash Glucose Monitoring system (FreeStyle Libre ) March 2018
Technology Commissioning Statement Flash Glucose Monitoring system (FreeStyle Libre ) March 2018 FreeStyle Libre (Abbott) Flash Glucose Monitoring System for use in adults, young people and children. Recommendation
More informationTHE SHEFFIELD AREA PRESCRIBING GROUP. Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes. Date: March 2018.
THE SHEFFIELD AREA PRESCRIBING GROUP Position Statement for Prescribing of Freestyle Libre In Type 1 Diabetes Date: March 2018 Overview Freestyle Libre is a flash glucose sensor device that measures *interstitial
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Non Cosmetic Nasal Surgery Policy For All Ages Prior Approval Policy Date Adopted: 19 th April 2017 Version: 1718.1 Individual Funding Request Team - A partnership
More informationPolicy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus
Policy for the Provision of Continuous Glucose Monitoring and Flash Glucose Monitoring to patients with Diabetes Mellitus Version No. Changes Made Version of 05.10.2018 V1 Policy ratified by Healthier
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Referrals to Secondary Care Pain Services for Assessment and Treatment Criteria Based Access Policy Date Adopted: Version: Development Individual Funding
More information1. Continuous Glucose Monitoring
1. Continuous Glucose Monitoring 1. Physiology of interstitial fluid glucose 2. Comparison of CGM and self-monitored blood glucose (SMBG) data 3. Insulin dosing indication in BGM vs. CGM & the FDA 4. Protection
More informationNHS GG&C Introduction of Freestyle Libre flash glucose monitoring system
NHS GG&C Introduction of Freestyle Libre flash glucose monitoring system The Freestyle Libre flash glucose monitoring system is a sensor based, factory-calibrated system that measures interstitial fluid
More informationFOI Summary Issue: IVF Policy. This information relates to Bristol Clinical Commissioning Group
FOI 1516 065 Summary Issue: IVF Policy This information relates to Bristol Clinical Commissioning Group 1. According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible
More informationShoulder Impingement Surgery for Subacromial Pain Policy CRITERIA BASED ACCESS (CBA) Policy
Shoulder Impingement Surgery for Subacromial Pain Policy CRITERIA BASED ACCESS (CBA) Policy Version: Recommendation by: 1819.v2a Date Ratified: 14 June 2018 Name of Originator/Author: Approved by Responsible
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationAnneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
More informationInsulin Pumps and Glucose Monitors in Adults Policy
Insulin Pumps and Glucose Monitors in Adults Policy Version: 2016-19 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on Performance and Risk Committee
More informationInsulin Pumps and Glucose Monitors in Adults, Children and Young People Policy
Insulin Pumps and Glucose Monitors in Adults, Children and Young People Policy Version: 2017-20 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 November 2016 NHS Leeds North CCG Governance on
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Non Cosmetic Nasal Treatment for All Ages Prior Approval Policy Date Adopted: 19 April 2017 Version: 1718.1.03 Individual Funding Request Team Bristol, North
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus This guidance was issued in
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Insulin pump use: ~ 20% - 30% of patients with T1DM < 1% of insulin-treated patients with T2DM 2007 FDA estimates ~375,000 insulin pumps for
More informationAudit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)
Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
More informationImplementation of Freestyle Libre prescribing guidance across the NHS in London
Implementation of FreeStyle Libre prescribing guidance across the NHS in London Contents Section 1 Background to the document (pages 2-5) Section 2 Implementation guidance pathways 1. Recommended implementation
More informationPaolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico
Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna Ipoglicemie e Monitoraggio Glicemico Management of Hypoglycaemia.if hypoglycemia is a problem, the principles
More informationFOI Summary Issue: IVF Policy. This information relates to Bristol Clinical Commissioning Group
FOI 1617 092 Summary Issue: IVF Policy This information relates to Bristol Clinical Commissioning Group 1. According to your current IVF treatment policy: a. How many cycles of IVF do you offer to eligible
More informationCGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set
More informationCorporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
More informationGuidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes
Introduction Guidance on the Self-Monitoring of Blood Glucose in Adults with Diabetes This guideline is designed to offer guidance for primary and secondary care on the use of selfmonitoring of blood glucose
More informationExtract from EFFECTIVE CLINICAL COMMISSIONING POLICIES
Extract from EFFECTIVE CLINICAL COMMISSIONING POLICIES CBA = criteria based access to treatment PA = prior approval must be obtained from the CCG prior to referral = intervention not normally funded; Individual
More informationNew NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people
Article New NICE guidance: Changes in practice for multidisciplinary teams. Part 1: Type 1 diabetes in children and young people Helen Thornton This is the first of two articles on the 2015 NICE NG18 guideline,
More informationFreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ
North Central London Joint Formulary Committee FreeStyle Libre for glucose monitoring: Interim Position Statement for GPs & Patient FAQ GPs should not prescribe FreeStyle Libre sensors on the NHS until
More informationDiabetes and Pregnancy
Diabetes and Pregnancy Dr Warren Gillibrand Deputy Director of Postgraduate Education Department of Nursing & Midwifery Department of AHP and Sports Science w.p.gillibrand@hud.ac.uk Aims of the session
More informationAdvances in Diabetes Care Technologies
1979 Advances in Diabetes Care Technologies 2015 Introduction Roughly 20% - 30% of patients with T1DM and fewer than 1% of insulin-treated patients with T2DM use an insulin pump In 2007, the US FDA estimated
More informationPersonal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup
1 Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup King s College London School of Medicine, Guy s Hospital, London SE1 9RT Experience of the technology I am the lead
More informationMonitoring in Type 2 Diabetes. Learning Outcomes. Type 2 Diabetes. Senga Hunter Community Diabetes Specialist Nurse
Monitoring in Type 2 Diabetes Senga Hunter Community Diabetes Specialist Nurse Learning Outcomes Understand why blood monitoring is necessary Understand the blood tests for monitoring diabetes Understand
More informationCommissioning Policy Individual Funding Request
Commissioning Policy Individual Funding Request Referral for Microsuction of Ear Wax, Discharge or Debris Removal in Secondary Care All Ages Criteria Based Access and Prior Approval Policy Date Adopted:
More informationContinuous Subcutaneous Insulin Infusion (CSII) pump therapy
Page 1 of 14 Continuous Subcutaneous Insulin Infusion (CSII) pump therapy Introduction This booklet has been compiled by the Insulin Pump Therapy Team to standardise the information given to patients on
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationGOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title
GOVERNING BOARD Date of Meeting 21 January 2015 Agenda Item No 13 Title Assisted Conception (IVF): Review of access criteria Purpose of Paper The SHIP (Southampton, Hampshire, Isle of Wight and Portsmouth)
More informationLong-term effects of continuous glucose monitoring on HbA 1c levels: An audit
Long-term effects of continuous glucose monitoring on Julie Brake Continuous glucose monitoring (CGM) has become a common and useful tool in diabetes care. To understand whether a 72-hour glucose profile
More informationCountry Health SA Local Health Network. Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service
Protocol (Clinical) Title: Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) Ambulatory Service Protocol developed by: CHSALHN Diabetes Service Protocol Sponsor: CHSALHN, Executive
More information